The latest update is out from MaxCyte ( (MXCT) ).
MaxCyte, Inc., a non-UK issuer, has announced a change in its major holdings. BlackRock, Inc., a major shareholder, has adjusted its voting rights in MaxCyte, now holding 7.81% of the total voting rights, up from a previous 7.73%. This adjustment reflects an acquisition or disposal of voting rights and financial instruments, indicating a strategic move by BlackRock, which could impact MaxCyte’s market dynamics and stakeholder interests.
More about MaxCyte
YTD Price Performance: -25.00%
Average Trading Volume: 40,604
Technical Sentiment Signal: Strong Buy
Current Market Cap: £253.6M
Learn more about MXCT stock on TipRanks’ Stock Analysis page.